Home » Topics » BioWorld Science

BioWorld Science
RSS

IDEC licenses rights to novel antiinflammatory technology

Sep. 11, 1997

Expanded uses of LifeCell's AlloDerm discussed at recent meeting

Sep. 11, 1997

Geron awarded SBIR grant for development of telomerase-based diagnostics

Sep. 11, 1997

PharmaPrint begins phase II trial of herbal treatment for BPH

Sep. 11, 1997

Lark signs DNA sequencing agreement with ZymoGenetics

Sep. 11, 1997

AMO Array Multifocal IOL approved for marketing in U.S.

Sep. 11, 1997

MiniMed and LRX combine forces for pulmonary hypertension treatment

Sep. 11, 1997

Topical foscarnet for treatment of herpes labialis

Sep. 11, 1997

Novartis launches Exelon

Sep. 11, 1997

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...